Papillary Thyroid Cancer Treatment - Global and China Top Players Market Share and Ranking 2023
According to Latest Study , the global market for Papillary Thyroid Cancer Treatment should grow from US$ 2750 million in 2023 to US$ 3815.6 million by 2030, with a CAGR of 4.8% for the period of 2024-2030.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Papillary Thyroid Cancer Treatment market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030. The United States Papillary Thyroid Cancer Treatment market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By segment, Hospital Pharmacies grew percent to account for percent of the total market sales, and Retail Pharmacies grew percent.
Papillary Thyroid Cancer is the most common type of thyroid cancer, representing 75 percent to 85 percent of all thyroid cancer cases. It occurs more frequently in women and presents in the 20–55 year age group. It is also the predominant cancer type in children with thyroid cancer, and in patients with thyroid cancer who have had previous radiation to the head and neck. It is often well-differentiated, slow-growing, and localized, although it can metastasize.
This report studies and analyses global Papillary Thyroid Cancer Treatment status and future trends, helps the client to determine the Papillary Thyroid Cancer Treatment market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Papillary Thyroid Cancer Treatment, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2023 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Papillary Thyroid Cancer Treatment market size, history data 2019-2024, and forecast data 2024 -2030, (US$ million) & (K Units)
(2) Global Papillary Thyroid Cancer Treatment sales, revenue, price by company, market share and industry ranking 2019-2024, (US$ million) & (K Units)
(3) China Papillary Thyroid Cancer Treatment sales, revenue, price by company, market share and industry ranking 2019-2024, (US$ million) & (K Units)
(4) Global Papillary Thyroid Cancer Treatment key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Papillary Thyroid Cancer Treatment key producing regions, capacity, production, and year over year growth
(6) Papillary Thyroid Cancer Treatment industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Mylan pharmaceuticals Inc.
Baxter International Inc.
Alara Pharmaceutical Corporation
Abbott laboratories
Bristol Myers co.
Teva parenteral medicines Inc.
Jerome Stevens Pharmaceuticals Inc.
Merck
Novartis
Pfizer
Sanofi
GalaxoSmithKline
Biogen Idec
Bayer Healthcare Pharmaceuticals
Johnson & Johnson
Tolero Pharmaceutical
Market segment by Type, covers
Surgery
Iodine Therapy
Thyroxin Treatment
Chemotherapy
Others
Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Papillary Thyroid Cancer Treatment product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Papillary Thyroid Cancer Treatment market share and ranking of major manufacturers, sales quantity, revenue, average price, 2019-2024
Chapter 3: China Papillary Thyroid Cancer Treatment market share and ranking of major manufacturers, sales quantity, revenue, average price, 2019-2024
Chapter 4: Global key producing regions of Papillary Thyroid Cancer Treatment, percent & CAGR, 2019-2030
Chapter 5: Papillary Thyroid Cancer Treatment industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Papillary Thyroid Cancer Treatment Definition
1.2 Global Papillary Thyroid Cancer Treatment Market Size and Forecast
1.2.1 By Consumption Value, Global Papillary Thyroid Cancer Treatment Market Size，2019-2030
1.2.2 By Sales Quantity, Global Papillary Thyroid Cancer Treatment Market Size，2019-2030
1.2.3 Global Papillary Thyroid Cancer Treatment Average Selling Price (ASP)，2019-2030
1.3 China Papillary Thyroid Cancer Treatment Market Size and Forecast
1.3.1 By Consumption Value, China Papillary Thyroid Cancer Treatment Market Size，2019-2030
1.3.2 By Sales Quantity, China Papillary Thyroid Cancer Treatment Market Size，2019-2030
1.3.3 China Papillary Thyroid Cancer Treatment Average Selling Price (ASP)， 2019-2030
1.4 Share of China Papillary Thyroid Cancer Treatment Market with Respect to the Global Market
1.4.1 By Consumption Value, China Papillary Thyroid Cancer Treatment Market Share in Global, 2019-2030
1.4.2 By Sales Quantity, China Papillary Thyroid Cancer Treatment Market Share in Global, 2019-2030
1.4.3 Papillary Thyroid Cancer Treatment Market Size: China VS Global, 2019-2030
1.5 Papillary Thyroid Cancer Treatment Market Dynamics
1.5.1 Papillary Thyroid Cancer Treatment Market Drivers
1.5.2 Papillary Thyroid Cancer Treatment Market Restraints
1.5.3 Papillary Thyroid Cancer Treatment Industry Trends
1.5.4 Papillary Thyroid Cancer Treatment Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Papillary Thyroid Cancer Treatment, Global Market Share by Company, 2019-2024
2.2 By Sales Quantity of Papillary Thyroid Cancer Treatment, Global Market Share by Company, 2019-2024
2.3 Papillary Thyroid Cancer Treatment Average Selling Price (ASP) by Company, 2019-2024
2.4 Global Papillary Thyroid Cancer Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Papillary Thyroid Cancer Treatment Concentration Ratio
2.6 Global Papillary Thyroid Cancer Treatment Mergers & Acquisitions, Expansion Plans
2.7 Global Papillary Thyroid Cancer Treatment Manufacturers Product Type
2.8 Head Office and Papillary Thyroid Cancer Treatment Production Site of Key Manufacturer
2.9 Papillary Thyroid Cancer Treatment Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Papillary Thyroid Cancer Treatment, China Market Share by Company, 2019-2024
3.2 By Sales Quantity of Papillary Thyroid Cancer Treatment, China Market Share by Company, 2019-2024
3.3 China Papillary Thyroid Cancer Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Papillary Thyroid Cancer Treatment Capacity, Output and Capacity Utilization, 2019-2030
4.2 Global Papillary Thyroid Cancer Treatment Capacity by Region
4.3 Global Papillary Thyroid Cancer Treatment Production & Forecast by Region, 2019 VS 2023 VS 2030
4.4 Global Papillary Thyroid Cancer Treatment Production by Region, 2019-2030
4.5 Global Papillary Thyroid Cancer Treatment Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Papillary Thyroid Cancer Treatment Industry Chain
5.2 Papillary Thyroid Cancer Treatment Upstream Analysis
5.2.1 Papillary Thyroid Cancer Treatment Core Raw Materials
5.2.2 Main Manufacturers of Papillary Thyroid Cancer Treatment Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Papillary Thyroid Cancer Treatment Production Mode
5.6 Papillary Thyroid Cancer Treatment Procurement Model
5.7 Papillary Thyroid Cancer Treatment Industry Sales Model and Sales Channels
5.7.1 Papillary Thyroid Cancer Treatment Sales Model
5.7.2 Papillary Thyroid Cancer Treatment Typical Distributors
6 Sights by Type
6.1 Papillary Thyroid Cancer Treatment Classification
6.1.1 Surgery
6.1.2 Iodine Therapy
6.1.3 Thyroxin Treatment
6.1.4 Chemotherapy
6.1.5 Others
6.2 By Type, Global Papillary Thyroid Cancer Treatment Consumption Value & CAGR, 2019 VS 2023 VS 2030
6.3 By Type, Global Papillary Thyroid Cancer Treatment Consumption Value, 2019-2030
6.4 By Type, Global Papillary Thyroid Cancer Treatment Sales Quantity, 2019-2030
6.5 By Type, Global Papillary Thyroid Cancer Treatment Average Selling Price (ASP), 2019-2030
7 Sights by Application
7.1 Papillary Thyroid Cancer Treatment Segment by Application
7.1.1 Hospital Pharmacies
7.1.2 Retail Pharmacies
7.1.3 Online Pharmacies
7.2 By Application, Global Papillary Thyroid Cancer Treatment Consumption Value & CAGR, 2019 VS 2023 VS 2030
7.3 By Application, Global Papillary Thyroid Cancer Treatment Consumption Value, 2019-2030
7.4 By Application, Global Papillary Thyroid Cancer Treatment Sales Quantity, 2019-2030
7.5 By Application, Global Papillary Thyroid Cancer Treatment Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Papillary Thyroid Cancer Treatment Consumption Value, 2019 VS 2023 VS 2030
8.2 By Region, Global Papillary Thyroid Cancer Treatment Consumption Value, 2019-2030
8.3 By Region, Global Papillary Thyroid Cancer Treatment Sales Quantity, 2019-2030
8.4 North America
8.4.1 North America Papillary Thyroid Cancer Treatment & Forecasts, 2019-2030
8.4.2 By Country, North America Papillary Thyroid Cancer Treatment Market Size Market Share
8.5 Europe
8.5.1 Europe Papillary Thyroid Cancer Treatment Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Papillary Thyroid Cancer Treatment Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Papillary Thyroid Cancer Treatment Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Papillary Thyroid Cancer Treatment Market Size Market Share
8.7 South America
8.7.1 South America Papillary Thyroid Cancer Treatment Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Papillary Thyroid Cancer Treatment Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Papillary Thyroid Cancer Treatment Market Size & CAGR, 2019 VS 2023 VS 2030
9.2 By Country, Global Papillary Thyroid Cancer Treatment Consumption Value, 2019-2030
9.3 By Country, Global Papillary Thyroid Cancer Treatment Sales Quantity, 2019-2030
9.4 U.S.
9.4.1 U.S. Papillary Thyroid Cancer Treatment Market Size, 2019-2030
9.4.2 By Type, U.S. Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2023 VS 2030
9.4.3 By Application, U.S. Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2023 VS 2030
9.5 Europe
9.5.1 Europe Papillary Thyroid Cancer Treatment Market Size, 2019-2030
9.5.2 By Type, Europe Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2023 VS 2030
9.5.3 By Application, Europe Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2023 VS 2030
9.6 China
9.6.1 China Papillary Thyroid Cancer Treatment Market Size, 2019-2030
9.6.2 By Type, China Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2023 VS 2030
9.6.3 By Application, China Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2023 VS 2030
9.7 Japan
9.7.1 Japan Papillary Thyroid Cancer Treatment Market Size, 2019-2030
9.7.2 By Type, Japan Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2023 VS 2030
9.7.3 By Application, Japan Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2023 VS 2030
9.8 South Korea
9.8.1 South Korea Papillary Thyroid Cancer Treatment Market Size, 2019-2030
9.8.2 By Type, South Korea Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2023 VS 2030
9.8.3 By Application, South Korea Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2023 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia Papillary Thyroid Cancer Treatment Market Size, 2019-2030
9.9.2 By Type, Southeast Asia Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2023 VS 2030
9.9.3 By Application, Southeast Asia Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2023 VS 2030
9.10 India
9.10.1 India Papillary Thyroid Cancer Treatment Market Size, 2019-2030
9.10.2 By Type, India Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2023 VS 2030
9.10.3 By Application, India Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2023 VS 2030
9.11 Middle East & Africa
9.11.1 Middle East & Africa Papillary Thyroid Cancer Treatment Market Size, 2019-2030
9.11.2 By Type, Middle East & Africa Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2023 VS 2030
9.11.3 By Application, Middle East & Africa Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2023 VS 2030
10 Manufacturers Profile
10.1 Mylan pharmaceuticals Inc.
10.1.1 Mylan pharmaceuticals Inc. Company Information, Head Office, Market Area, and Industry Position
10.1.2 Mylan pharmaceuticals Inc. Papillary Thyroid Cancer Treatment Models, Specifications, and Application
10.1.3 Mylan pharmaceuticals Inc. Papillary Thyroid Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Mylan pharmaceuticals Inc. Company Profile and Main Business
10.1.5 Mylan pharmaceuticals Inc. Recent Developments
10.2 Baxter International Inc.
10.2.1 Baxter International Inc. Company Information, Head Office, Market Area, and Industry Position
10.2.2 Baxter International Inc. Papillary Thyroid Cancer Treatment Models, Specifications, and Application
10.2.3 Baxter International Inc. Papillary Thyroid Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.2.4 Baxter International Inc. Company Profile and Main Business
10.2.5 Baxter International Inc. Recent Developments
10.3 Alara Pharmaceutical Corporation
10.3.1 Alara Pharmaceutical Corporation Company Information, Head Office, Market Area, and Industry Position
10.3.2 Alara Pharmaceutical Corporation Papillary Thyroid Cancer Treatment Models, Specifications, and Application
10.3.3 Alara Pharmaceutical Corporation Papillary Thyroid Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Alara Pharmaceutical Corporation Company Profile and Main Business
10.3.5 Alara Pharmaceutical Corporation Recent Developments
10.4 Abbott laboratories
10.4.1 Abbott laboratories Company Information, Head Office, Market Area, and Industry Position
10.4.2 Abbott laboratories Papillary Thyroid Cancer Treatment Models, Specifications, and Application
10.4.3 Abbott laboratories Papillary Thyroid Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Abbott laboratories Company Profile and Main Business
10.4.5 Abbott laboratories Recent Developments
10.5 Bristol Myers co.
10.5.1 Bristol Myers co. Company Information, Head Office, Market Area, and Industry Position
10.5.2 Bristol Myers co. Papillary Thyroid Cancer Treatment Models, Specifications, and Application
10.5.3 Bristol Myers co. Papillary Thyroid Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Bristol Myers co. Company Profile and Main Business
10.5.5 Bristol Myers co. Recent Developments
10.6 Teva parenteral medicines Inc.
10.6.1 Teva parenteral medicines Inc. Company Information, Head Office, Market Area, and Industry Position
10.6.2 Teva parenteral medicines Inc. Papillary Thyroid Cancer Treatment Models, Specifications, and Application
10.6.3 Teva parenteral medicines Inc. Papillary Thyroid Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Teva parenteral medicines Inc. Company Profile and Main Business
10.6.5 Teva parenteral medicines Inc. Recent Developments
10.7 Jerome Stevens Pharmaceuticals Inc.
10.7.1 Jerome Stevens Pharmaceuticals Inc. Company Information, Head Office, Market Area, and Industry Position
10.7.2 Jerome Stevens Pharmaceuticals Inc. Papillary Thyroid Cancer Treatment Models, Specifications, and Application
10.7.3 Jerome Stevens Pharmaceuticals Inc. Papillary Thyroid Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Jerome Stevens Pharmaceuticals Inc. Company Profile and Main Business
10.7.5 Jerome Stevens Pharmaceuticals Inc. Recent Developments
10.8 Merck
10.8.1 Merck Company Information, Head Office, Market Area, and Industry Position
10.8.2 Merck Papillary Thyroid Cancer Treatment Models, Specifications, and Application
10.8.3 Merck Papillary Thyroid Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Merck Company Profile and Main Business
10.8.5 Merck Recent Developments
10.9 Novartis
10.9.1 Novartis Company Information, Head Office, Market Area, and Industry Position
10.9.2 Novartis Papillary Thyroid Cancer Treatment Models, Specifications, and Application
10.9.3 Novartis Papillary Thyroid Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.9.4 Novartis Company Profile and Main Business
10.9.5 Novartis Recent Developments
10.10 Pfizer
10.10.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.10.2 Pfizer Papillary Thyroid Cancer Treatment Models, Specifications, and Application
10.10.3 Pfizer Papillary Thyroid Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.10.4 Pfizer Company Profile and Main Business
10.10.5 Pfizer Recent Developments
10.11 Sanofi
10.11.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.11.2 Sanofi Papillary Thyroid Cancer Treatment Models, Specifications, and Application
10.11.3 Sanofi Papillary Thyroid Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.11.4 Sanofi Company Profile and Main Business
10.11.5 Sanofi Recent Developments
10.12 GalaxoSmithKline
10.12.1 GalaxoSmithKline Company Information, Head Office, Market Area, and Industry Position
10.12.2 GalaxoSmithKline Papillary Thyroid Cancer Treatment Models, Specifications, and Application
10.12.3 GalaxoSmithKline Papillary Thyroid Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.12.4 GalaxoSmithKline Company Profile and Main Business
10.12.5 GalaxoSmithKline Recent Developments
10.13 Biogen Idec
10.13.1 Biogen Idec Company Information, Head Office, Market Area, and Industry Position
10.13.2 Biogen Idec Papillary Thyroid Cancer Treatment Models, Specifications, and Application
10.13.3 Biogen Idec Papillary Thyroid Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.13.4 Biogen Idec Company Profile and Main Business
10.13.5 Biogen Idec Recent Developments
10.14 Bayer Healthcare Pharmaceuticals
10.14.1 Bayer Healthcare Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.14.2 Bayer Healthcare Pharmaceuticals Papillary Thyroid Cancer Treatment Models, Specifications, and Application
10.14.3 Bayer Healthcare Pharmaceuticals Papillary Thyroid Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.14.4 Bayer Healthcare Pharmaceuticals Company Profile and Main Business
10.14.5 Bayer Healthcare Pharmaceuticals Recent Developments
10.15 Johnson & Johnson
10.15.1 Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
10.15.2 Johnson & Johnson Papillary Thyroid Cancer Treatment Models, Specifications, and Application
10.15.3 Johnson & Johnson Papillary Thyroid Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.15.4 Johnson & Johnson Company Profile and Main Business
10.15.5 Johnson & Johnson Recent Developments
10.16 Tolero Pharmaceutical
10.16.1 Tolero Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.16.2 Tolero Pharmaceutical Papillary Thyroid Cancer Treatment Models, Specifications, and Application
10.16.3 Tolero Pharmaceutical Papillary Thyroid Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.16.4 Tolero Pharmaceutical Company Profile and Main Business
10.16.5 Tolero Pharmaceutical Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Papillary Thyroid Cancer Treatment Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Papillary Thyroid Cancer Treatment Market Restraints
Table 3. Papillary Thyroid Cancer Treatment Market Trends
Table 4. Papillary Thyroid Cancer Treatment Industry Policy
Table 5. Global Papillary Thyroid Cancer Treatment Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Papillary Thyroid Cancer Treatment Revenue Share by Company, 2019-2024, Ranked by Data of 2022
Table 7. Global Papillary Thyroid Cancer Treatment Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Papillary Thyroid Cancer Treatment Sales Quantity by Company, 2019-2024, Ranked by Data of 2022
Table 9. Global Papillary Thyroid Cancer Treatment Average Selling Price (ASP) by Company, (2019-2024) & (US$/Unit)
Table 10. Global Papillary Thyroid Cancer Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Papillary Thyroid Cancer Treatment Mergers & Acquisitions, Expansion Plans
Table 12. Global Papillary Thyroid Cancer Treatment Manufacturers Product Type
Table 13. Head Office and Papillary Thyroid Cancer Treatment Production Site of Key Manufacturer
Table 14. Papillary Thyroid Cancer Treatment Capacity of Major Manufacturers and Future Plan
Table 15. China Papillary Thyroid Cancer Treatment Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022
Table 16. China Papillary Thyroid Cancer Treatment Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022
Table 17. China Papillary Thyroid Cancer Treatment Sales Quantity by Company, 2019-2024, Ranked by Data of 2022
Table 18. Global Papillary Thyroid Cancer Treatment Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 19. Global Papillary Thyroid Cancer Treatment Production by Region, 2019-2024, (K Units)
Table 20. Global Papillary Thyroid Cancer Treatment Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Papillary Thyroid Cancer Treatment Upstream (Raw Materials)
Table 22. Global Papillary Thyroid Cancer Treatment Typical Customers
Table 23. Papillary Thyroid Cancer Treatment Typical Distributors
Table 24. By Type, Global Papillary Thyroid Cancer Treatment Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 25. By Application, Global Papillary Thyroid Cancer Treatment Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 26. By Region, Global Papillary Thyroid Cancer Treatment Consumption Value, 2019 VS 2024 VS 2030, US$ Million
Table 27. By Region, Global Papillary Thyroid Cancer Treatment Consumption Value, 2019-2030, US$ Million
Table 28. By Region, Global Papillary Thyroid Cancer Treatment Sales Quantity, 2019-2030, (K Units)
Table 29. By Country, Global Papillary Thyroid Cancer Treatment Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Country, Global Papillary Thyroid Cancer Treatment Consumption Value, 2019-2030, US$ Million
Table 31. By Country, Global Papillary Thyroid Cancer Treatment Consumption Value Market Share, 2019-2030
Table 32. By Country, Global Papillary Thyroid Cancer Treatment Sales Quantity, 2019-2030, (K Units)
Table 33. By Country, Global Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2019-2030
Table 34. Mylan pharmaceuticals Inc. Company Information, Head Office, Market Area, and Industry Position
Table 35. Mylan pharmaceuticals Inc. Papillary Thyroid Cancer Treatment Models, Specifications, and Application
Table 36. Mylan pharmaceuticals Inc. Papillary Thyroid Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 37. Mylan pharmaceuticals Inc. Company Profile and Main Business
Table 38. Mylan pharmaceuticals Inc. Recent Developments
Table 39. Baxter International Inc. Company Information, Head Office, Market Area, and Industry Position
Table 40. Baxter International Inc. Papillary Thyroid Cancer Treatment Models, Specifications, and Application
Table 41. Baxter International Inc. Papillary Thyroid Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. Baxter International Inc. Company Profile and Main Business
Table 43. Baxter International Inc. Recent Developments
Table 44. Alara Pharmaceutical Corporation Company Information, Head Office, Market Area, and Industry Position
Table 45. Alara Pharmaceutical Corporation Papillary Thyroid Cancer Treatment Models, Specifications, and Application
Table 46. Alara Pharmaceutical Corporation Papillary Thyroid Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. Alara Pharmaceutical Corporation Company Profile and Main Business
Table 48. Alara Pharmaceutical Corporation Recent Developments
Table 49. Abbott laboratories Company Information, Head Office, Market Area, and Industry Position
Table 50. Abbott laboratories Papillary Thyroid Cancer Treatment Models, Specifications, and Application
Table 51. Abbott laboratories Papillary Thyroid Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. Abbott laboratories Company Profile and Main Business
Table 53. Abbott laboratories Recent Developments
Table 54. Bristol Myers co. Company Information, Head Office, Market Area, and Industry Position
Table 55. Bristol Myers co. Papillary Thyroid Cancer Treatment Models, Specifications, and Application
Table 56. Bristol Myers co. Papillary Thyroid Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. Bristol Myers co. Company Profile and Main Business
Table 58. Bristol Myers co. Recent Developments
Table 59. Teva parenteral medicines Inc. Company Information, Head Office, Market Area, and Industry Position
Table 60. Teva parenteral medicines Inc. Papillary Thyroid Cancer Treatment Models, Specifications, and Application
Table 61. Teva parenteral medicines Inc. Papillary Thyroid Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. Teva parenteral medicines Inc. Company Profile and Main Business
Table 63. Teva parenteral medicines Inc. Recent Developments
Table 64. Jerome Stevens Pharmaceuticals Inc. Company Information, Head Office, Market Area, and Industry Position
Table 65. Jerome Stevens Pharmaceuticals Inc. Papillary Thyroid Cancer Treatment Models, Specifications, and Application
Table 66. Jerome Stevens Pharmaceuticals Inc. Papillary Thyroid Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 67. Jerome Stevens Pharmaceuticals Inc. Company Profile and Main Business
Table 68. Jerome Stevens Pharmaceuticals Inc. Recent Developments
Table 69. Merck Company Information, Head Office, Market Area, and Industry Position
Table 70. Merck Papillary Thyroid Cancer Treatment Models, Specifications, and Application
Table 71. Merck Papillary Thyroid Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 72. Merck Company Profile and Main Business
Table 73. Merck Recent Developments
Table 74. Novartis Company Information, Head Office, Market Area, and Industry Position
Table 75. Novartis Papillary Thyroid Cancer Treatment Models, Specifications, and Application
Table 76. Novartis Papillary Thyroid Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 77. Novartis Company Profile and Main Business
Table 78. Novartis Recent Developments
Table 79. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 80. Pfizer Papillary Thyroid Cancer Treatment Models, Specifications, and Application
Table 81. Pfizer Papillary Thyroid Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 82. Pfizer Company Profile and Main Business
Table 83. Pfizer Recent Developments
Table 84. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 85. Sanofi Papillary Thyroid Cancer Treatment Models, Specifications, and Application
Table 86. Sanofi Papillary Thyroid Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 87. Sanofi Company Profile and Main Business
Table 88. Sanofi Recent Developments
Table 89. GalaxoSmithKline Company Information, Head Office, Market Area, and Industry Position
Table 90. GalaxoSmithKline Papillary Thyroid Cancer Treatment Models, Specifications, and Application
Table 91. GalaxoSmithKline Papillary Thyroid Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 92. GalaxoSmithKline Company Profile and Main Business
Table 93. GalaxoSmithKline Recent Developments
Table 94. Biogen Idec Company Information, Head Office, Market Area, and Industry Position
Table 95. Biogen Idec Papillary Thyroid Cancer Treatment Models, Specifications, and Application
Table 96. Biogen Idec Papillary Thyroid Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 97. Biogen Idec Company Profile and Main Business
Table 98. Biogen Idec Recent Developments
Table 99. Bayer Healthcare Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 100. Bayer Healthcare Pharmaceuticals Papillary Thyroid Cancer Treatment Models, Specifications, and Application
Table 101. Bayer Healthcare Pharmaceuticals Papillary Thyroid Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 102. Bayer Healthcare Pharmaceuticals Company Profile and Main Business
Table 103. Bayer Healthcare Pharmaceuticals Recent Developments
Table 104. Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
Table 105. Johnson & Johnson Papillary Thyroid Cancer Treatment Models, Specifications, and Application
Table 106. Johnson & Johnson Papillary Thyroid Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 107. Johnson & Johnson Company Profile and Main Business
Table 108. Johnson & Johnson Recent Developments
Table 109. Tolero Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 110. Tolero Pharmaceutical Papillary Thyroid Cancer Treatment Models, Specifications, and Application
Table 111. Tolero Pharmaceutical Papillary Thyroid Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 112. Tolero Pharmaceutical Company Profile and Main Business
Table 113. Tolero Pharmaceutical Recent Developments
List of Figures
Figure 1. Papillary Thyroid Cancer Treatment Picture
Figure 2. Global Papillary Thyroid Cancer Treatment Consumption Value, (US$ million) & (2019-2030)
Figure 3. Global Papillary Thyroid Cancer Treatment Sales Quantity, (K Units) & (2019-2030)
Figure 4. Global Papillary Thyroid Cancer Treatment Average Selling Price (ASP), (2019-2030) & (US$/Unit)
Figure 5. China Papillary Thyroid Cancer Treatment Consumption Value, (US$ million) & (2019-2030)
Figure 6. China Papillary Thyroid Cancer Treatment Sales Quantity (K Units) & (2019-2030)
Figure 7. China Papillary Thyroid Cancer Treatment Average Selling Price (ASP), (US$/Unit) & (2019-2030)
Figure 8. By Consumption Value, China Papillary Thyroid Cancer Treatment Market Share of Global, 2019-2030
Figure 9. By Sales Quantity, China Papillary Thyroid Cancer Treatment Market Share of Global, 2019-2030
Figure 10. Global Papillary Thyroid Cancer Treatment Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Papillary Thyroid Cancer Treatment Key Participants, Market Share, 2022
Figure 12. Global Papillary Thyroid Cancer Treatment Capacity, Production and Capacity Utilization, 2019-2030
Figure 13. Global Papillary Thyroid Cancer Treatment Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Papillary Thyroid Cancer Treatment Production Market Share & Forecast by Region, 2019-2030
Figure 15. Papillary Thyroid Cancer Treatment Industry Chain
Figure 16. Papillary Thyroid Cancer Treatment Procurement Model
Figure 17. Papillary Thyroid Cancer Treatment Sales Model
Figure 18. Papillary Thyroid Cancer Treatment Sales Channels, Direct Sales, and Distribution
Figure 19. Surgery
Figure 20. Iodine Therapy
Figure 21. Thyroxin Treatment
Figure 22. Chemotherapy
Figure 23. Others
Figure 24. By Type, Global Papillary Thyroid Cancer Treatment Consumption Value, 2019-2030, US$ Million
Figure 25. By Type, Global Papillary Thyroid Cancer Treatment Consumption Value Market Share, 2019-2030
Figure 26. By Type, Global Papillary Thyroid Cancer Treatment Sales Quantity, 2019-2030, (K Units)
Figure 27. By Type, Global Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2019-2030
Figure 28. By Type, Global Papillary Thyroid Cancer Treatment Average Selling Price (ASP), 2019-2030, (US$/Unit)
Figure 29. Hospital Pharmacies
Figure 30. Retail Pharmacies
Figure 31. Online Pharmacies
Figure 32. By Application, Global Papillary Thyroid Cancer Treatment Consumption Value, 2019-2030, US$ Million
Figure 33. By Application, Global Papillary Thyroid Cancer Treatment Consumption Value Market Share, 2019-2030
Figure 34. By Application, Global Papillary Thyroid Cancer Treatment Sales Quantity, 2019-2030, (K Units)
Figure 35. By Application, Global Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2019-2030
Figure 36. By Application, Global Papillary Thyroid Cancer Treatment Average Selling Price (ASP), 2019-2030, (US$/Unit)
Figure 37. By Region, Global Papillary Thyroid Cancer Treatment Consumption Value Market Share, 2019-2030
Figure 38. By Region, Global Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2019-2030
Figure 39. North America Papillary Thyroid Cancer Treatment Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 40. By Country, North America Papillary Thyroid Cancer Treatment Consumption Value Market Share, 2022
Figure 41. Europe Papillary Thyroid Cancer Treatment Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 42. By Country, Europe Papillary Thyroid Cancer Treatment Consumption Value Market Share, 2022
Figure 43. Asia Pacific Papillary Thyroid Cancer Treatment Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 44. By Country/Region, Asia Pacific Papillary Thyroid Cancer Treatment Consumption Value Market Share, 2022
Figure 45. South America Papillary Thyroid Cancer Treatment Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 46. By Country, South America Papillary Thyroid Cancer Treatment Consumption Value Market Share, 2022
Figure 47. Middle East & Africa Papillary Thyroid Cancer Treatment Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 48. U.S. Papillary Thyroid Cancer Treatment Sales Quantity, 2019-2030, (K Units)
Figure 49. By Type, U.S. Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, U.S. Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 51. Europe Papillary Thyroid Cancer Treatment Sales Quantity, 2019-2030, (K Units)
Figure 52. By Type, Europe Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, Europe Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 54. China Papillary Thyroid Cancer Treatment Sales Quantity, 2019-2030, (K Units)
Figure 55. By Type, China Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, China Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 57. Japan Papillary Thyroid Cancer Treatment Sales Quantity, 2019-2030, (K Units)
Figure 58. By Type, Japan Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, Japan Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 60. South Korea Papillary Thyroid Cancer Treatment Sales Quantity, 2019-2030, (K Units)
Figure 61. By Type, South Korea Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, South Korea Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 63. Southeast Asia Papillary Thyroid Cancer Treatment Sales Quantity, 2019-2030, (K Units)
Figure 64. By Type, Southeast Asia Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, Southeast Asia Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 66. India Papillary Thyroid Cancer Treatment Sales Quantity, 2019-2030, (K Units)
Figure 67. By Type, India Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, India Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 69. Middle East & Africa Papillary Thyroid Cancer Treatment Sales Quantity, 2019-2030, (K Units)
Figure 70. By Type, Middle East & Africa Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 71. By Application, Middle East & Africa Papillary Thyroid Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 72. Research Methodology
Figure 73. Breakdown of Primary Interviews
Figure 74. Bottom-up and Top-down Approaches
Figure 75. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|